Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Cytokines and Growth Factors as Predictors of Response to Medical Treatment in Diabetic Macular Edema
Publication

Publications

Cytokines and Growth Factors as Predictors of Response to Medical Treatment in Diabetic Macular Edema

Title
Cytokines and Growth Factors as Predictors of Response to Medical Treatment in Diabetic Macular Edema
Type
Article in International Scientific Journal
Year
2020
Authors
Torres Costa, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alves Valente, MCA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Falcão-Reis F
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Manuel Falcão
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Other information
Authenticus ID: P-00S-GKB
Abstract (EN): Diabetic macular edema (DME) is the most common cause of visual loss in patients with diabetes. Antivascular endothelial growth factors (anti-VEGF) agents are first-line therapy for DME. Nevertheless, up to 60% of patients (depending on the antiVEGF drug used) have an inadequate response to anti-VEGF treatment. Several cytokines are increased in aqueous humor of patients with DME. Differences in response to treatment may be related to baseline cytokine levels. Intravitreal corticosteroids may be used as an alternative to anti-VEGF agents. Steroids have a different pharmacological profile and act on different pathophysiologic mechanisms. Their effect on aqueous humor cytokines is different from the effect of anti-VEGF therapy. This review highlights the major cytokines involved in DME and evaluates whether baseline cytokine levels could be predictors of response to treatment in DME. SIGNIFICANCE STATEMENT Antivascular endothelial growth factor (anti-VEGF) agents are efficient as diabetic macular edema (DME) treatment. However, in some cases, DME fails to respond to anti-VEGF intravitreal injections. Changes in cytokine levels after treatment supported the idea that other cytokines than VEGF are implicated in DME pathogenesis and could be predictors of response to anti-VEGF treatment or corticosteroids allowing targeted and individualized therapy guided by cytokine levels.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase (1997)
Article in International Scientific Journal
Borges, Nuno; vieira-coelho, ma; Parada, A; soares-da-silva, p
STUDIES ON THE ROLE OF SODIUM ON THE SYNTHESIS OF DOPAMINE IN THE RAT-KIDNEY (1993)
Article in International Scientific Journal
Soares-da-Silva P; Fernandes MH; Pestana M
Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia (2006)
Article in International Scientific Journal
Capela, JP; Meisel, A; Abreu, AR; Branco, PS; Ferreira, LM; Lobo, AM; Remiao, F; Bastos, ML; Carvalho, F
LACK OF PREJUNCTIONAL AND POSTJUNCTIONAL BETA-ADRENOCEPTOR-MEDIATED EFFECTS IN THE CANINE SAPHENOUS-VEIN AT BIRTH (1994)
Article in International Scientific Journal
GUIMARAES, S; moura, d; PAIVA, MQ; Vaz Da Silva, M

See all (11)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-25 at 02:20:35 | Privacy Policy | Personal Data Protection Policy | Whistleblowing